IGFBP2 and colorectal cancer: LRG1 has been identified to be differentially expressed in colorectal cancer, and a panel of the CEA, IGFBP2, MAPRE1, and LRG1 proteins is potentially a prediagnostic marker in colorectal cancer plasma samples [12].